I. D. Raikin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
I. D. Raikin has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
A. Sopotov
1 shared publication- Andrey I. Yaroshetskiy
Sechenov First Moscow State Medical University, Moscow, Russia
1 shared publication - Artem A. Burenkin
Altai State Medical University
1 shared publication - Igor A. Zakharchenko
City Clinical Hospital named after F.I. Inozemtsev, Moscow, Russia
1 shared publication M. Gatkin
1 shared publication- Maxim I. Savelenok
Pulmonology Department, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 96-118
Airway pressure release ventilation versus pressure controlled ventilation with PEEP based on zero end-expiratory transpulmonary pressure in patients with secondary ARDS: a randomized open-label clinical trial
INTRODUCTION: Data on direct comparison of airway pressure release ventilation (APRV) with other modes using transpulmonary pressure monitoring are scarce. OBJECTIVE: to compare gas exchange, respiratory mechanics, and hemodynamics between APRV (APRV group) and pressure-controlled ventilation with positive end-expiratory pressure (PEEP) set at zero end-expiratory transpulmonary pressure (PCV-PL group) in patients with early secondary acute respiratory distress syndrome (ARDS). MATERIALS AND METHODS: A randomized open-label study conducted in 35 surgical patients with ARDS on mechanical ventilation < 24 h. We measured oxygenation and ventilation indices along with airway and transpulmonary pressures, and hemodynamic variables during first 7 days after enrollment. RESULTS: Total PEEP on Day 1 was 20.5 (17.3–22.0) vs 18.0 (15.0–22.0) cmH2O in APRV group and in PCV-PL group, respectively (p = 0.099). PaO2/FiO2 was higher in APRV only on Day 3 (p = 0.023). Patients in PCV-PL group had lower exhaled tidal volume during all days (p < 0.05 for all). The ventilatory ratio was significantly higher in APRV group at Days 3, 4, and 5 (p < 0.05 for all). Inspiratory (PLPPLAT) and end-expiratory (PLPEEP) transpulmonary pressures was higher in APRV group at Day 1, and PLPEEP was higher at Day 3 in APRV group (p < 0.05 for all). Driving PL was higher in APRV group at Day 1. Central venous pressure was higher in APRV group at Days 3 and 6 (p < 0.05 for all). Patients in APRV group had significantly higher heart rate at Days 1, 2, 5, 6, and 7 (p < 0.05 for all). Cumulative norepinephrine score during the first 72 h was higher in APRV group (p = 0.043). Duration of mechanical ventilation and mortality did not differ between groups. CONCLUSIONS: Total PEEP levels and oxygenation indices in patients with secondary ARDS in PCV-PL group were comparable to APRV mode, though APRV could promote lung overdistension, dynamic strain and have negative hemodynamic impact.
- 31 October 2026
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 96-118
Open AccessAirway pressure release ventilation versus pressure controlled ventilation with PEEP based on zero end-expiratory transpulmonary pressure in patients with secondary ARDS: a randomized open-label clinical trial
INTRODUCTION: Data on direct comparison of airway pressure release ventilation (APRV) with other modes using transpulmonary pressure monitoring are scarce. OBJECTIVE: to compare gas exchange, respiratory mechanics, and hemodynamics between APRV (APRV group) and pressure-controlled ventilation with positive end-expiratory pressure (PEEP) set at zero end-expiratory transpulmonary pressure (PCV-PL group) in patients with early secondary acute respiratory distress syndrome (ARDS). MATERIALS AND METHODS: A randomized open-label study conducted in 35 surgical patients with ARDS on mechanical ventilation < 24 h. We measured oxygenation and ventilation indices along with airway and transpulmonary pressures, and hemodynamic variables during first 7 days after enrollment. RESULTS: Total PEEP on Day 1 was 20.5 (17.3–22.0) vs 18.0 (15.0–22.0) cmH2O in APRV group and in PCV-PL group, respectively (p = 0.099). PaO2/FiO2 was higher in APRV only on Day 3 (p = 0.023). Patients in PCV-PL group had lower exhaled tidal volume during all days (p < 0.05 for all). The ventilatory ratio was significantly higher in APRV group at Days 3, 4, and 5 (p < 0.05 for all). Inspiratory (PLPPLAT) and end-expiratory (PLPEEP) transpulmonary pressures was higher in APRV group at Day 1, and PLPEEP was higher at Day 3 in APRV group (p < 0.05 for all). Driving PL was higher in APRV group at Day 1. Central venous pressure was higher in APRV group at Days 3 and 6 (p < 0.05 for all). Patients in APRV group had significantly higher heart rate at Days 1, 2, 5, 6, and 7 (p < 0.05 for all). Cumulative norepinephrine score during the first 72 h was higher in APRV group (p = 0.043). Duration of mechanical ventilation and mortality did not differ between groups. CONCLUSIONS: Total PEEP levels and oxygenation indices in patients with secondary ARDS in PCV-PL group were comparable to APRV mode, though APRV could promote lung overdistension, dynamic strain and have negative hemodynamic impact.
- Open Access
- 24 October 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 20 (5) , 67-75
Risk factors, criteria and biomarkers of acute kidney injury in the perioperative period
It is becoming increasingly important to prevent complications of surgical treatment, including perioperative acute kidney injury due to prolongation of life expectancy and age-related multicomorbidity. The objective was to review the recommendations of the expert groups and the studу results on risk factors, criteria and biomarkers of perioperative acute kidney injury.Materials and methods. Reports on search results for the last 15 years as of May 15, 2023 in the eLibrary, PubMed databases for the keywords «acute kidney injury», «biomarker», «perioperative period». The inclusion of reports in the review and their evaluation are based on the authors consensus. Results. In the perioperative period, acute kidney injury without a decrease in diuresis and/or an increase in serum creatinine levels up to a certain time may occur. This condition, which varies in causes and mechanisms of development, is potentially reversible with timely detection and treatment. The study of both biomarkers that surpass creatinine and diuresis in the timing and accuracy of detecting kidney damage/dysfunction, as well as tools for a comprehensive assessment and risk stratification of perioperative acute kidney injury, have not yet been completed with evidence-based conclusions. Conclusion. The strategy of using laboratory biomarkers in combination with the clinical context and risk factors for the prevention, diagnosis and treatment of subclinical acute kidney injury of various origins, supported by the Acute Disease Quality Initiative (2020), could be implemented based on additional evidence from future clinical studies.
- 24 October 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 20 (5) , 67-75
Open AccessRisk factors, criteria and biomarkers of acute kidney injury in the perioperative period
It is becoming increasingly important to prevent complications of surgical treatment, including perioperative acute kidney injury due to prolongation of life expectancy and age-related multicomorbidity. The objective was to review the recommendations of the expert groups and the studу results on risk factors, criteria and biomarkers of perioperative acute kidney injury.Materials and methods. Reports on search results for the last 15 years as of May 15, 2023 in the eLibrary, PubMed databases for the keywords «acute kidney injury», «biomarker», «perioperative period». The inclusion of reports in the review and their evaluation are based on the authors consensus. Results. In the perioperative period, acute kidney injury without a decrease in diuresis and/or an increase in serum creatinine levels up to a certain time may occur. This condition, which varies in causes and mechanisms of development, is potentially reversible with timely detection and treatment. The study of both biomarkers that surpass creatinine and diuresis in the timing and accuracy of detecting kidney damage/dysfunction, as well as tools for a comprehensive assessment and risk stratification of perioperative acute kidney injury, have not yet been completed with evidence-based conclusions. Conclusion. The strategy of using laboratory biomarkers in combination with the clinical context and risk factors for the prevention, diagnosis and treatment of subclinical acute kidney injury of various origins, supported by the Acute Disease Quality Initiative (2020), could be implemented based on additional evidence from future clinical studies.
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e61-e62
Dual shockwave and using high-flow oxygen administration by nasal cannula (HFONC) may improve lithotripsy results
- 1 March 2017
- Published by Elsevier in European Urology Supplements
- Vol. 16 (3) , e61-e62
Dual shockwave and using high-flow oxygen administration by nasal cannula (HFONC) may improve lithotripsy results